SME Times is powered by   
Search News
Just in:   • Coal production from India's commercial mines jumps 16.4 pc in April-June quarter  • India poised to become 3rd-largest economy by 2030, overtaking Germany: Hardeep Puri  • India's industrial production registers 1.2 per cent growth in May  • Govt committed to building safe and smart energy future: Minister  • Sanchez defends Spain's defence budget in response to Trump's threats 
Last updated: 14 Jan, 2022  

Tablet.9.Thmb.jpg Aurobindo Pharma shares slump on USFDA warning letter to Hyderabad unit

Tablet.9.jpg
   Top Stories
» India poised to become 3rd-largest economy by 2030, overtaking Germany: Hardeep Puri
» India's industrial production registers 1.2 per cent growth in May
» Govt committed to building safe and smart energy future: Minister
» QCOs benefit MSMEs by enhancing product quality, consumer satisfaction: Piyush Goyal
» Stock market opens higher as Trump indicates ‘great’ trade deal with India
SME Times News Bureau | 14 Jan, 2022
Shares of pharmaceutical firm Aurobindo Pharma declined nearly 5 per cent on Friday after global watchdog USFDA (United States Food and Drug Administration) sent a warning letter to the company in connection to its unit in Hyderabad.

According to reports, the USFDA through the letter warned the firm for poor manufacturing practices, problems with claims for what a product can do, or incorrect directions for usage.

Later in the day, the shares of the company, however, pared some of its intraday losses and settled 3 per cent down at Rs 696.

The pharmaceutical company, through a regulatory filing, confirmed that it received the letter from the USFDA.

"This action follows the recent inspection of the Unit by the USFDA in August 2021. The Company believes that this will not impact the existing business from this facility. The Company will be engaging with the regulator and is fully committed in resolving this issue at the earliest," it said in the filing on Friday.

"The Company is also committed to maintaining the highest quality manufacturing standards at all of its facilities across the globe," it added.

Aurobindo Pharma exports its products to over 155 countries across the globe with more than 90 per cent of its revenues derived from international operations.
 
Print the Page
Add to Favorite
 
Share this on :
 

Please comment on this story:
 
Subject :
Message:
(Maximum 1500 characters)  Characters left 1500
Your name:
 

 
  Customs Exchange Rates
Currency Import Export
US Dollar
84.35
82.60
UK Pound
106.35
102.90
Euro
92.50
89.35
Japanese Yen 55.05 53.40
As on 12 Oct, 2024
  Daily Poll
Do you think Indian businesses will be negatively affected by Trump's America First Policy?
 Yes
 No
 Can't Say
  Commented Stories
 
 
About Us  |   Advertise with Us  
  Useful Links  |   Terms and Conditions  |   Disclaimer  |   Contact Us  
Follow Us : Facebook Twitter